DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Efungumab
Efungumab
Phage Display-Based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed Against Human Pathogens
Monoclonal Antibodies As Tools to Combat Fungal Infections
Therapeutic Monoclonal Antibody for Sporotrichosis
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
(INN) for Biological and Biotechnological Substances
Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
Adverse Events/Mode of Action Relationship of Monoclonal Antibodies-Based Therapies: Overview of Marketed Products in the European Union
An Insight Into the Antifungal Pipeline: Selected New Molecules and Beyond
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
Refusal Public Assessment Report
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Generation and Characterization of Single Chain Variable Fragment Against Alpha-Enolase of Candida Albicans
Top View
History and Practice: Antibodies in Infectious Diseases ADAM HEY1 1Preclinical Safety, Biologics, Novartis AG, Basel, Switzerland
Who Drug Information
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Antifungal Drugs: New Insights in Research & Development
Fig. 2 O W O 2012/149282 A2 1Inn Iiiiiii 1Mil I Mil Il I 1Ill I Mil I Il I I Mill Mi I I
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Pharmaceutical Substances (INN)
Drugs in Clinical Development for Fungal Infections
The Protective Role of Immunoglobulins in Fungal Infections and Inflammation
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
European Expert Opinion on the Management of Invasive Candidiasis in Adults
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri